• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Vorolanib Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759284

MBS5759284 is an inhibitor targeting Vorolanib. Vorolanib is an orally active VEGFR/PDGFR dual inhibitor. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Vorolanib, Inhibitor
Full Product Name
Vorolanib
Product Synonym Names
CM082; X-82
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
439.48
Solubility
DMSO: 22mg/mL (50.06mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C23H26FN5O3
SMILES
CN(C)C(=O)N1CC[C@@H](C1)NC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C
CAS Number
1013920-15-4
Target & IC50
VEGFR
PDGFR

Structure of Vorolanib, inhibitor

Vorolanib Inhibitor – Cat# MBS5759284

Product References and Citations for Vorolanib, inhibitor

Bendell JC, et al. Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors. Oncologist. 2019 Apr;24(4):455-e121.

Other Notes

Small volumes of Vorolanib, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000